C152H132Cl6N30O7 — CID 159489831
1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-(azetidin-1-yl)ethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-cyclohexylethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)ethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-(3-methylpyrrol-1-yl)ethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-morpholin-4-ylethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-pyrrolidin-1-ylethanone (PubChem CID 159489831) has the molecular formula C152H132Cl6N30O7 and a molecular weight of 2703.65 g/mol. Its IUPAC name is 1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-(azetidin-1-yl)ethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-cyclohexylethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)ethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-(3-methylpyrrol-1-yl)ethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-morpholin-4-ylethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-pyrrolidin-1-ylethanone.
| Compound Name | 1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-(azetidin-1-yl)ethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-cyclohexylethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)ethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-(3-methylpyrrol-1-yl)ethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-morpholin-4-ylethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-pyrrolidin-1-ylethanone |
|---|---|
| PubChem CID | 159489831 |
| Molecular Formula | C152H132Cl6N30O7 |
| Molecular Weight | 2703.65 g/mol |
| Exact Mass | 2698.90 |
| IUPAC Name | 1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-(azetidin-1-yl)ethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-cyclohexylethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-(3-methylimidazolidin-1-yl)ethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-(3-methylpyrrol-1-yl)ethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-morpholin-4-ylethanone;1-[3-amino-6-(8-chloroquinolin-6-yl)-5-phenylpyrazin-2-yl]-2-pyrrolidin-1-ylethanone |
| SMILES | CN1CCN(CC(=O)c2nc(-c3cc(Cl)c4ncccc4c3)c(-c3ccccc3)nc2N)C1.Cc1ccn(CC(=O)c2nc(-c3cc(Cl)c4ncccc4c3)c(-c3ccccc3)nc2N)c1.Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3ncccc3c2)nc1C(=O)CC1CCCCC1.Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3ncccc3c2)nc1C(=O)CN1CCC1.Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3ncccc3c2)nc1C(=O)CN1CCCC1.Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3ncccc3c2)nc1C(=O)CN1CCOCC1 |
| InChI | InChI=1S/C27H25ClN4O.C26H20ClN5O.C25H23ClN6O.C25H22ClN5O2.C25H22ClN5O.C24H20ClN5O/c28-21-16-20(15-19-12-7-13-30-23(19)21)25-24(18-10-5-2-6-11-18)32-27(29)26(31-25)22(33)14-17-8-3-1-4-9-17;1-16-9-11-32(14-16)15-21(33)25-26(28)31-23(17-6-3-2-4-7-17)24(30-25)19-12-18-8-5-10-29-22(18)20(27)13-19;1-31-10-11-32(15-31)14-20(33)24-25(27)30-22(16-6-3-2-4-7-16)23(29-24)18-12-17-8-5-9-28-21(17)19(26)13-18;26-19-14-18(13-17-7-4-8-28-21(17)19)23-22(16-5-2-1-3-6-16)30-25(27)24(29-23)20(32)15-31-9-11-33-12-10-31;26-19-14-18(13-17-9-6-10-28-21(17)19)23-22(16-7-2-1-3-8-16)30-25(27)24(29-23)20(32)15-31-11-4-5-12-31;25-18-13-17(12-16-8-4-9-27-20(16)18)22-21(15-6-2-1-3-7-15)29-24(26)23(28-22)19(31)14-30-10-5-11-30/h2,5-7,10-13,15-17H,1,3-4,8-9,14H2,(H2,29,32);2-14H,15H2,1H3,(H2,28,31);2-9,12-13H,10-11,14-15H2,1H3,(H2,27,30);1-8,13-14H,9-12,15H2,(H2,27,30);1-3,6-10,13-14H,4-5,11-12,15H2,(H2,27,30);1-4,6-9,12-13H,5,10-11,14H2,(H2,26,29) |
| InChIKey | LYAVVHDOMASFKW-UHFFFAOYSA-N |
| XLogP | 29.78 |
| TPSA | 520.92 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 37 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 195 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2703.65 |
| LogP ≤ 5 | 29.78 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 37 |